Cambridge Healthtech Institute’s 5th Annual
Bioproduction: Scale, Bioreactors & Disposables
Making It Work
August 5-6, 2015
Part of CHI's 7th Annual The Bioprocessing Summit
August 3-7, 2015 | Westin Copley Place Hotel | Boston, Massachusetts
This meeting will look at the bigger picture of bioprocessing while exploring the details of optimizing processes, both from a practical and an engineering viewpoint, particularly bioreactor engineering. Creating models for scaling down and scaling up, as well as disposables, will also be discussed, as will monitoring and analyzing processes in order to reach optimal conditions and productivity. Examining how bioreactors process cells will be addressed, from small operational details to large-scale bioproduction.
OPENING KEYNOTE PRESENTATION:
Planning for the Future: Manufacturing Capacity Versus Demand Uncertainty
Peter F. Moesta, Ph.D., Senior Vice President, Biologics Manufacturing & Process Development, Bristol Myers Squibb Co.
Fc-Fusions versus mABs: Opportunities and Limits of Platform Processes
Stefan Schmidt, Ph.D., M.B.A., Vice President, GMP Operations, Rentschler Biotechnologie GmbH
Challenges in N-1 Perfusion Process Optimization
Weimin Lin, Ph.D., Process Development Scientist, Biogen Idec, Inc.
Points to Consider when Scaling Up Raw Materials in Your Manufacturing Process
David Kolwyck, M.B.A., Director, Manufacturing Science - Raw Materials, Biogen Idec
Technology Transfer when Scaling Up Processes
Jayant Aphale, Ph.D., M.B.A., Senior Vice President, Technical Operations, Sarepta Therapeutics
Scale-Down Models for Upstream Cell Culture Processes
Eric J. Wallenstein, Ph.D., Associate Principal Scientist, Biologics Manufacturing Science & Commercialization, Merck & Co., Inc. – tentative
Overcoming Scale-Down Model Development Challenges for MAb Production
Gayle E. Derfus, Ph.D., Senior Research Scientist I, Gilead Sciences
Talk Title to be Announced
Akash Joshi, MSc., Scientist, Boehringer Ingelheim
Scale-Down Model Development in Single-Use Minibioreactors
Hao Chen, Ph.D., Director, Upstream Process Development, BioProcess R&D, Merck Research Laboratories
The Effect of Microspargers on Product Quality Variability in Large-Scale Perfusion Bioreactors
Nirel Rillera, Research Associate, BioMarin Pharmaceuticals, Inc.
For more details on the conference,
Senior Conference Director
For exhibit & sponsorship opportunities, please contact: